Learn more about Monash Health’s Haematology team.
Dr Shaun Fleming
Shaun Fleming is a haematologist and bone marrow transplant physician with co-appointments at Monash Health and Alfred Health. Shaun has a particular interest in allogeneic stem cell transplantation (alloHSCT) and in acute leukaemia. He is the lead investigator on studies in acute lymphoblastic leukaemia (ALL) including the recently completed ALL08 study which evaluated the usage of novel immunotherapies in the management of older adults with B-ALL and leads the MrDRIVE study to investigate MRD directed therapy in older adults with B-ALL.
Shaun is co-chair of the Optimal Care Pathways initiative in ALL and is a member of the Australasian Leukaemia and Lymphoma Group (ALLG), ALL working party. His research interests include immunotherapies in ALL including chimeric antigen receptor T-cells (CART), novel therapies in ALL, allogeneic stem cell transplant risk stratification, measurable residual disease assessment and the application of machine learning to haematology practice.
Through his position at Monash Health, Shaun helps facilitate access for Monash patients to allogeneic stem cell transplantation ensuring their early assessment, risk stratification and management through the transplant process, and facilitating their ongoing care at Monash Health following the completion of their allogeneic stem cell transplant.